Health and Pharmaceutical Industry

Health industry is an industry that can constitute both small and big companies and also can provide goods and services. Therefore, we can say that health sector contains many different subjects related to tax. This sector comprises of entities and individuals providing direct attention like hospitals, pharmacies, polyclinics, doctor practices, nursing centers.

Medicine companies and medical equipment producers are the two which are developing direct products to treat the patients. This group also involves the companies like laboratory service providers producing goods and services for illness diagnosis. There are also many technology companies providing technology services and infrastructure needed to health industry in order to treat patients and keep data in safe.

Medicine market in Turkey has an increasing trend since the beginning of the 1990s. This growth especially accelerated after 2001 economic crisis. In the same period, medicine companies have increased their revenues and also profitability. Our country was not affected much by the crisis because of the fact that products produced by the sector are not savings products and thus, consumption did not face with a serious decline.

Turkey’s increasing economy and daily growing investment potential has caused an upward trend in interests of local and foreign investors to Turkey in recent years. Investments to the health sector and increasing trend in mergers and acquisitions made great contribution to the development of the sector. In the last period, health sector made progress correspondingly to the supports and incentives of government.

Research and Development Expenditures in Medicine Sector

R&D includes laboratory and clinical exercises that makes current treatments more developed and it gives an opportunity to have different choices for disease diagnosis and treatments.

The main purpose at developing medicine is to make a better recovery in human life. It is important to achieve treater and minimizer the symptoms of the illnesses with each improved medicine and vaccine application. Therefore, R&D expenditures matter. Along with the original medicines, equivalent medicines are also produced and released to the market. These equivalent imitated medicines are the products released after the end of the protection time period of the original medicines. These products have the same effects with original ones. Equivalent medicines constitute an important part of world medicine market. Equivalent medicines that constitute approximately %25 of the world medicine market have bigger portions in developing countries in terms of production and sales. Therefore, because production of medicine has a serious portion in the companies’ budgets, we are giving services about incentives in R&D expenditures with our professional team.

Our Services in the Sector

As Vizyon, some services that we are providing as a result of huge long-time sectoral experience and practices are the followings: